Filter registries KELA purch., KELA reimb.
Check pre-conditions None
Include endpoints None
Check conditions None
Apply sex-specific rule None
RX_L02BA
Extra metadata
List of similar endpoints to
L02BA Anti-estrogens
based on the number of shared cases.
Broader endpoints:
Narrower endpoints:
None
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 3118 | 3063 | 55 |
| Unadjusted prevalence (%) | 1.20 | 2.08 | 0.05 |
| Mean age at first event (years) | 57.37 | 57.27 | 62.81 |
| Follow-up | Absolute risk | HR [95% CI] | p | N |
|---|---|---|---|---|
| 1998–2019 | 0.06 | 3.98 [2.61, 6.08] | 1.5e-10 | 292 |
| 15 years | 0.03 | 4.68 [3.14, 6.98] | 3.6e-14 | 267 |
| 5 years | 0.01 | 8.27 [5.99, 11.40] | 6.0e-38 | 130 |
| 1 year | 0.00 | 7.55 [4.64, 12.30] | 4.5e-16 | 23 |
Index endpoint: RX_L02BA – L02BA Anti-estrogens
GWS hits:
before L02BA Anti-estrogens
after L02BA Anti-estrogens
Loading survival analyses plot
Loading survival analyses table